Disease & disorder
inflammatory bowel disease
MONDO:0005265
A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
21 shownCOVID-19 Booster and IIV Schedule in Immunocompromised HostsNCT06599658 · 2024-11-20
RECRUITINGFluorescence Imaging of IBD and RA Using Adalimumab-800CWNCT03938701 · 2024-08-06
RECRUITINGTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsNCT04751396 · 2022-04-20
RECRUITINGTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345 · 2019-07-16
RECRUITINGHealth and Exercise Response in Children With Chronic and Auto-immune PathologiesNCT03913962 · 2019-05-02
RECRUITINGIntegrating Vaccination Into Hospital Care Pathways for Vulnerable PatientsNCT07391046 · 2026-02-01
NOT_YET_RECRUITINGA Clinical Study to Evaluate SM17 in Healthy ParticipantsNCT07466940 · 2025-10-14
COMPLETEDAcceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.NCT07380022 · 2025-07-09
COMPLETEDThe Living With a Long-Term Condition StudyNCT06072287 · 2023-06-28
UNKNOWNConception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and InflammationNCT04902807 · 2021-09-07
COMPLETEDMental Health in Children and Youth Within Pediatric CareNCT04094324 · 2020-10-01
UNKNOWNChanges of Muramyl Dipeptide in Intestinal and Extra-intestinal DiseasesNCT04924686 · 2020-05-10
UNKNOWNA Trial to Determine the Effects of Exercise in Inflammatory Bowel Disease and Rheumatoid ArthritisNCT02463916 · 2015-03-01
UNKNOWNEffects of Fasting on Self EfficacyNCT02113111 · 2014-04-01
COMPLETED25-hydroxyvitamin D and Fatigue: The VITALITY StudyNCT01718925 · 2012-10-01
COMPLETEDIncidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive AnalysisNCT02922192 · 2012-01-01
COMPLETEDSurgicAl Metabolic Phenotyping Longitudinal Evaluation StudyNCT01378013 · 2011-08-01
COMPLETEDPrognostic Indicators as Provided by the EPIC ClearViewNCT01476995 · 2010-09-01
COMPLETEDMD2Me - Texting to Promote Chronic Disease ManagementNCT01253733 · 2009-10-01
COMPLETEDAnalysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and PsoriasisNCT00658827 · 2007-01-01
COMPLETEDSirolimus for Autoimmune Disease of Blood CellsNCT00392951 · 2006-12-01
COMPLETEDDrugs being studied
Research locations
BaltimoreMaryland, United States2HoustonTexas, United States2PhiladelphiaPennsylvania, United States2AtlantaGeorgia, United States1BethesdaMaryland, United States1BirminghamAlabama, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1Clermont-FerrandFrance1ColumbusOhio, United States1DallasTexas, United States1DetroitMichigan, United States1
Leading sponsors
Biologics & Biosimilars Collective Intelligence Consortium1Children's Hospital of Philadelphia1Epic Research & Diagnostics, Inc.1Fondazione Policlinico Universitario Agostino Gemelli IRCCS1Huang, Jeannie, M.D.1Imperial College London1Institut National de la Santé Et de la Recherche Médicale, France1Janssen Biotech, Inc.1King's College London1M.D. Anderson Cancer Center1McGill University Health Centre/Research Institute of the McGill University Health Centre1National Cancer Institute (NCI)1Ostfold Hospital Trust1Region Skane1SinoMab BioScience Ltd1
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.